TABLE 1.
Participant Characteristics and Samples Available for Each Assay
| Characteristic | Control, n = 7 | Sleep-Deprived, n = 7 | Drug, n = 6 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age, yr | ||||||||||||
| Mean | 47.6 | 48.1 | 51 | |||||||||
| SD | 9.2 | 10 | 9.8 | |||||||||
| Sex, M/F | 2/5 | 3/4 | 3/3 | |||||||||
| Race, C/AA | 3/4 | 3/4 | 2/4 | |||||||||
| Samples Available for Each Assay | ||||||||||||
| Participant | Control | Sleep-Deprived | Drug | |||||||||
| Aβ | Tau/p-tau | α-synuclein | pS129-α-synuclein | Aβ | Tau/p-tau | α-synuclein | pS129-α-synuclein | Aβ | Tau/p-tau | α-synuclein | pS129-α-synuclein | |
| 1 | X | X | X | BLD | X | X | X | BLD | X | X | X | BLD |
| 2 | X | X | X | BLD | X | X | X | BLD | X | X | X | BLD |
| 3 | X | X | X | X | X | X | X | X | X | X | X | X |
| 4 | X | X | X | BLD | X | X | X | BLD | X | X | X | BLD |
| 5 | X | X | — | — | X | X | — | — | — | — | — | — |
| 6 | X | X | X | BLD | X | X | — | — | — | — | — | — |
| 7 | X | X | X | X | — | — | — | — | X | X | X | X |
| 8 | — | — | — | — | X | X | X | X | X | X | X | X |
AA = African American; Aβ = amyloid-β; BLD = below detection limit; C = Caucasian; F = female; M = male; p-tau = phosphorylated tau;